Dr. Soiffer is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
44 Binney St
# Dana
Boston, MA 02115Phone+1 617-632-4731Fax+1 617-632-5175
Education & Training
- Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 1986 - 1989
- Brigham and Women's HospitalResidency, Internal Medicine, 1983 - 1986
- New York University School of MedicineClass of 1983
Certifications & Licensure
- FL State Medical License 2022 - Present
- MA State Medical License 1986 - 2025
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2010-2014
- Boston Magazine Castle Connolly, 2009-2013
- America's Top Doctors for Cancer Castle Connolly, 2009-2013
- Join now to see all
Clinical Trials
- Acute Myeloid Leukemia T Cell Depletion to Improve Transplants in Adults With Acute Myeloid Leukemia (BMT CTN 0303) Start of enrollment: 2005 Jun 01
- Abatacept to Treat Steroid Refractory Chronic Graft Versus Host Disease (cGVHD) Start of enrollment: 2014 Mar 27
Publications & Presentations
PubMed
- Tracking Rare Single Donor and Recipient Immune and Leukemia Cells after Allogeneic Hematopoietic Cell Transplantation Using Mitochondrial DNA Mutations.Livius Penter, Nicoletta Cieri, Katie Maurer, Marwan Kwok, Haoxiang Lyu
Blood Cancer Discovery. 2024-11-01 - Health-related quality of life with gilteritinib vs placebo posttransplant for FLT3-ITD+ acute myeloid leukemia.Betty K Hamilton, Bhavik J Pandya, Cristina Ivanescu, Dina Elsouda, Mehdi Hamadani
Blood Advances. 2024-10-08 - 1 citationsNon-pathogenic E. coli displaying decoy-resistant IL18 mutein boosts anti-tumor and CAR NK cell responses.Shaobo Yang, Michal Sheffer, Isabel E Kaplan, Zongqi Wang, Mubin Tarannum
Nature Biotechnology. 2024-10-04
Journal Articles
- Small-Molecule BCL6 Inhibitor Effectively Treats Mice with Non-Sclerodermatous Chronic Graft-Versus-Host DiseaseJoseph H Antin, Bruce Blazar, Leo Luznik, John Koreth, Ivan Maillard, Robert J Soiffer, James E Bradner, Jonathan S Serody, Jerome Ritz, Blood
Abstracts/Posters
- Distinct Evolutionary Patterns in Chronic Lymphocytic Leukemia (CLL) during Resistance to Graft-Versus-Leukemia (GvL)Robert J. Soiffer, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Feasibility and Impact of Embedded Geriatric Consultation for Frail Older Adults with Blood Cancer: A Randomized Controlled TrialRobert J. Soiffer, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Improved Outcomes with Cyclophosphamide/Total Body Irradiation 14 Gy Compared to Cyclophosphamide/Total Body Irradiation 12 Gy in Patients with Acute Lymphoblastic Leu...Robert J. Soiffer, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Join now to see all
Lectures
- BMT Peds and Adult61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
- Progression Risk-Based Classification of Asymptomatic Waldenström Macroglobulinemia2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Allogeneic Stem Cell Transplantation Provides Durable Remission in Patients with Primary Mediastinal Large B-Cell Lymphoma2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
Press Mentions
- Gut Bacteria Engineered to Act as Tumor GPS for ImmunotherapiesOctober 4th, 2024
- New Research Offers Hope for Safer and More Effective Blood Stem Cell TransplantsSeptember 4th, 2024
- Drug Companies Set Sights on New COVID Medicines to Boost Depleted ArsenalDecember 27th, 2022
- Join now to see all
Grant Support
- Immune Modulation/Hematopoietic Cell TransplantationNational Institute Of Allergy And Infectious Diseases2005–2010
- Induction Of Anti-Tumor Immunity After Allogeneic Hematopoietic Cell TransplantNational Institute Of Allergy And Infectious Diseases2007–2009
- Induction Of Anti-Tumor Immunity After HC TransplantNational Institute Of Allergy And Infectious Diseases2005–2006
- Administrative &Communications CoreNational Institute Of Allergy And Infectious Diseases2005
- T Cell Infusions After Stem Cell TransplantationNational Institute Of Allergy And Infectious Diseases2000–2002
- Immunologic Manipulation Of Donor Marrow PRE And Post Allogeneic BMTNational Institute Of Allergy And Infectious Diseases1996–1998
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: